Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines

被引：0
|
作者：
Steffen Zopf
Matthias Ocker
Daniel Neureiter
Beate Alinger
Susanne Gahr
Markus F Neurath
Pietro Di Fazio
机构：
[1] University Hospital Erlangen,Department of Medicine 1
[2] Paracelsus Medical University,Institute of Pathology
[3] Klinikum Nuremberg Nord,Department of Pneumology
[4] Philipps University Marburg,Institute for Surgical Research
来源：
BMC Cancer | / 12卷
关键词：
DNA methyltransferase; Deacetylase inhibitor; Epigenetics; Transcriptional control; Hepatocellular carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma
    Richardson, Paul G.
    Laubach, Jacob P.
    Lonial, Sagar
    Moreau, Philippe
    Yoon, Sung-Soo
    Hungria, Vania T. M.
    Dimopoulos, Meletios A.
    Beksac, Meral
    Alsina, Melissa
    San-Miguel, Jesus F.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (07) : 737 - 748
  • [12] THE PAN-DEACETYLASE INHIBITOR PANOBINOSTAT (LBH 589) INHIBITS DNA METHYLTRANSFERASES IN HCC IN VITRO AND IN VIVO
    Zopf, Steffen
    Di Fazio, Pietro
    Gahr, Susanne
    Strobel, Deike
    Neurath, Markus F.
    Ocker, Matthias
    HEPATOLOGY, 2010, 52 (04) : 945A - 946A
  • [13] The Pan-Deacetylase Inhibitor Panobinostat Downregulates HIF-1α and VEGF and, Synergizes With Everolimus In Hodgkin Lymphoma Cell Lines
    Lemoine, Manuela
    Buglio, Daniela
    Jona, Adam
    Derenzini, Enrico
    Medeiros, L. Jeffrey
    Berry, Donald A.
    Younes, Anas
    BLOOD, 2010, 116 (21) : 1174 - 1175
  • [14] Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines
    Di Fazio, Pietro
    Montalbano, Roberta
    Neureiter, Daniel
    Alinger, Beate
    Schmidt, Ansgar
    Merkel, Anna Lena
    Quint, Karl
    Ocker, Matthias
    EXPERIMENTAL CELL RESEARCH, 2012, 318 (15) : 1832 - 1843
  • [15] Endoplasmic Reticulum Stress Plays a Pivotal Role in Cell Death Mediated by the Pan-Deacetylase Inhibitor Panobinostat in Human Hepatocellular Cancer Cells
    Montalbano, Roberta
    Waldegger, Petra
    Quint, Karl
    Jabari, Samir
    Neureiter, Daniel
    Illig, Romana
    Ocker, Matthias
    Di Fazio, Pietro
    TRANSLATIONAL ONCOLOGY, 2013, 6 (02): : 143 - U211
  • [16] Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors
    Prince, H. Miles
    Bishton, Mark J.
    Johnstone, Ricky W.
    FUTURE ONCOLOGY, 2009, 5 (05) : 601 - 612
  • [17] Endoplasmic reticulum stress mediates cell death in human hepatocellular cancer cells: an alternative apoptotic pathway induced by the pan-deacetylase inhibitor panobinostat
    Montalbano, R.
    Di Fazio, P.
    Wissniowski, T.
    Gahr, S.
    Quint, K.
    Ocker, M.
    EJC SUPPLEMENTS, 2010, 8 (05): : 102 - 102
  • [18] ER-stress activation in human hepatocellular cancer cells: an alternative death pathway induced by the pan-deacetylase inhibitor panobinostat
    Ocker, M.
    di Fazio, P.
    Montalbano, R.
    Quint, K.
    Gahr, S.
    Wissniowski, T.
    ONKOLOGIE, 2010, 33 : 161 - 161
  • [19] Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma (vol 15, pg 737, 2015)
    Richardson, P. G.
    Laubach, J. P.
    Lonial, S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (09) : 1121 - 1121
  • [20] Potent preclinical antitumor effects induced by pan-histone deacetylase inhibitor panobinostat in combination with sorafenib in hepatocellular carcinoma
    Toffanin, Sara
    Lachenmayer, Anja
    Alsinet, Clara
    Cabellos, Laia
    Minguez, Beatriz
    Tsai, Hung-Wen
    Hoshida, Yujin
    Villanueva, Augusto
    Ward, Stephen C.
    Thung, Swan
    Friedman, Scott L.
    Llovet, Josep M.
    CANCER RESEARCH, 2012, 72
12345